Dual Antiplatelet Therapy Duration for Ischemic Stroke and TIA

Standard Duration: 21 Days for Minor Stroke/High-Risk TIA

• The American College of Cardiology recommends using 21 days of dual antiplatelet therapy (aspirin + clopidogrel) for minor ischemic stroke (NIHSS ≤3) or high-risk TIA (ABCD2 ≥4), as this duration provides maximum benefit while minimizing bleeding risk 1, 2
• Initiate DAPT in patients with minor ischemic stroke (NIHSS 0-3) or high-risk TIA (ABCD2 score ≥4) of noncardioembolic origin within 24 hours of symptom onset 2
• Continuing DAPT beyond 21-30 days significantly increases major hemorrhage risk without additional benefit 1, 2

Dosing Protocol for 21-Day Regimen

• Day 1: Aspirin 160-325 mg + clopidogrel 300-600 mg (loading dose) 1, 2
• Days 2-21: Aspirin 75-100 mg daily + clopidogrel 75 mg daily 1, 2

Extended Duration: 90 Days for Intracranial Atherosclerosis

• Use 90 days of DAPT (aspirin 325 mg + clopidogrel 75 mg) specifically for patients with recently symptomatic intracranial stenosis (70-99%) as part of aggressive medical management 3

Key Exclusion Criteria for DAPT

• Do not use DAPT in patients with moderate to severe stroke (NIHSS >3), low-risk TIA (ABCD2 <4), symptom onset >24 hours, cardioembolic stroke, intracranial hemorrhage on imaging, or high bleeding risk 1, 2

Critical Safety Considerations

• Major hemorrhage risk increases with DAPT (RR 1.88-1.90) compared to aspirin alone 2
• Consider gastroprotection with proton pump inhibitors in patients with gastrointestinal bleeding risk factors during the 21-day DAPT period 1, 2